Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Smith

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Jac-Antimicrobial Resistance|July 23, 2025
Combatting mobile colistin-resistant (MCR), metallo-β-lactamase (MBL)-producing <i>Klebsiella pneumoniae</i> persistersJack F Klem, Jan Naseer Kaur, Yang Liu, et al.
Clinical Pharmacology and Therapeutics|December 8, 2023
Machine Learning-Led Optimization of Combination Therapy: Confronting the Public Health Threat of Extensively Drug Resistant Gram-Negative BacteriaNicholas M Smith, Thomas D Nguyen, Thomas P Lodise, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Resensitizing the Untreatable: Zidovudine and Polymyxin Combinations to Combat Pan-Drug-Resistant <i>Klebsiella pneumoniae</i>Jan Naseer Kaur, Jack F Klem, Gebremedhin S Hailu, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Translational Quantitative Proteomic Assay for Bacteriophages: A New Frontier in Phage Pharmaceutical DevelopmentThomas D Nguyen, Connor E Gould, Jacob T Sanborn, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Pharmacodynamic Evaluation of Adjuvant Targets: Low Molecular Weight PBP7/8 Effects on β-Lactam Activity Against Carbapenem-Resistant Acinetobacter BaumanniiBrian M Ho, Jingxiu Jin, Jacob T Sanborn, et al.
Clinical and Translational Science|January 27, 2026
Enhanced Clearance of HIV-1 Broadly Neutralizing Antibody VRC07-523-LS During Viremia: Influences on Trial Design and AnalysisNicholas M Smith, Brian M Ho, Katharine J Bar, et al.
Antimicrobial Agents and Chemotherapy|August 4, 2022
Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane IntegrityNicholas M Smith, Katie Rose Boissonneault, Liang Chen, et al.
Antimicrobial Agents and Chemotherapy|February 8, 2024
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in <i>in vitro</i> media, and novel supplement dosing strategy to mitigate thermal drug degradationJieqiang Zhou, Yuli Qian, Yinzhi Lang, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Jac-Antimicrobial Resistance|July 23, 2025
Combatting mobile colistin-resistant (MCR), metallo-β-lactamase (MBL)-producing <i>Klebsiella pneumoniae</i> persistersJack F Klem, Jan Naseer Kaur, Yang Liu, et al.
Clinical Pharmacology and Therapeutics|December 8, 2023
Machine Learning-Led Optimization of Combination Therapy: Confronting the Public Health Threat of Extensively Drug Resistant Gram-Negative BacteriaNicholas M Smith, Thomas D Nguyen, Thomas P Lodise, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Resensitizing the Untreatable: Zidovudine and Polymyxin Combinations to Combat Pan-Drug-Resistant <i>Klebsiella pneumoniae</i>Jan Naseer Kaur, Jack F Klem, Gebremedhin S Hailu, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Translational Quantitative Proteomic Assay for Bacteriophages: A New Frontier in Phage Pharmaceutical DevelopmentThomas D Nguyen, Connor E Gould, Jacob T Sanborn, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Pharmacodynamic Evaluation of Adjuvant Targets: Low Molecular Weight PBP7/8 Effects on β-Lactam Activity Against Carbapenem-Resistant Acinetobacter BaumanniiBrian M Ho, Jingxiu Jin, Jacob T Sanborn, et al.
Clinical and Translational Science|January 27, 2026
Enhanced Clearance of HIV-1 Broadly Neutralizing Antibody VRC07-523-LS During Viremia: Influences on Trial Design and AnalysisNicholas M Smith, Brian M Ho, Katharine J Bar, et al.
Antimicrobial Agents and Chemotherapy|August 4, 2022
Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane IntegrityNicholas M Smith, Katie Rose Boissonneault, Liang Chen, et al.
Antimicrobial Agents and Chemotherapy|February 8, 2024
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in <i>in vitro</i> media, and novel supplement dosing strategy to mitigate thermal drug degradationJieqiang Zhou, Yuli Qian, Yinzhi Lang, et al.
Pageof 4